Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Oberman, Allan Grant. Insider active across 1 company, notably Apotex Health Corp.. Aggregated, 9 filings have been recorded. Split: 1 buy · 0 sell. Total volume traded: €11.3m. History available since 18 September 2026. The latest transaction was filed on 18 September 2026 (15 - Acquisition or disposition under a prospectus). Regulator: SEDI. The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Oberman, Allan Grant is a declarant linked to Apotex Health Corp. as 4 - Director of Issuer. The record shows 5 filings in total, and the sampled recent filings cover the period from 2026-06-18 to 2026-08-19, with 0 EUR of buys and 0 EUR of sells; the most frequent transaction nature is 00 - Opening Balance-Initial SEDI Report.